[High-dose immunoglobulin during pregnancy for two patients with risk of recurrent neonatal haemochromatosis]. / Traitement par immunoglobulines pendant la grossesse chez deux patientes à risque de récurrence d'hémochromatose néonatale.
J Gynecol Obstet Biol Reprod (Paris)
; 36(4): 409-12, 2007 Jun.
Article
in Fr
| MEDLINE
| ID: mdl-17446006
ABSTRACT
Two patients, with prior affected children with Neonatal Haemochromatosis [NH], benefited from intravenous immunoglobulin treatment during their following pregnancy in order to prevent recurrent NH. Whereas NH is a severe disease with high risk of recurrence and high mortality rate (about 80%), a recent treatment was suggested in the USA, which seems to completely modify the prognosis of this pathology. We proposed this treatment for two patients with indeed apparent benefit, giving birth to two healthy babies.
Search on Google
Collection:
01-internacional
Health context:
2_ODS3
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Immunoglobulins
/
Hemochromatosis
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Newborn
/
Pregnancy
Language:
Fr
Journal:
J Gynecol Obstet Biol Reprod (Paris)
Year:
2007
Document type:
Article